Search
Lineage Cell Therapeutics Inc
LCTXAdd to Watchlist
1.350USD
+0.045+3.46%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
336.55MMarket Cap
LossP/E TTM
Lineage Cell Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
14.56M
53.24%
EPS(YoY)
-0.28
-197.00%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its total revenue reached 14.56M, with a year-on-year change of 53.24.
What are the current assets of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its current assets were 59.16M, with a year-on-year change of 16.00.
What are the total assets of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its total assets of Lineage Cell Therapeutics Inc were 112.58M, with a year-on-year change of -0.56.
What are the total liabilities of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its total liabilities of Lineage Cell Therapeutics Inc were 69.24M, with a year-on-year change of 91.23.
What is the total equity of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its total equity of Lineage Cell Therapeutics Inc was 43.35M, with a year-on-year change of -43.72.
What is the net investment of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its net investment of Lineage Cell Therapeutics Inc was -13.46M, with a year-on-year change of -483.06.
What is the net financing of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its net financing of Lineage Cell Therapeutics Inc was 26.95M, with a year-on-year change of -24.84.
What is the Earnings Per Share (EPS) of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.28, with a year-on-year change of -197.00.
What is the net margin of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its net profit margin was -435.33, with a year-on-year change of -122.54.
What is the gross margin of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its gross margin was 99.00, with a year-on-year change of 2.60.
What is the debt-to-asset ratio of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.06, with a year-on-year change of -43.12.
What is the Return on Equity (ROE) of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -103.36, with a year-on-year change of -293.82.
What is the Return on Assets (ROA) of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -56.13, with a year-on-year change of -223.55.
What is the operating profit of Lineage Cell Therapeutics Inc?
According to Lineage Cell Therapeutics Inc's FY2025 earnings report, its operating profit was -21.78M, with a year-on-year change of -1.40.